BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34325833)

  • 1. Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.
    Schachtl-Riess JF; Kheirkhah A; Grüneis R; Di Maio S; Schoenherr S; Streiter G; Losso JL; Paulweber B; Eckardt KU; Köttgen A; Lamina C; Kronenberg F; Coassin S;
    J Am Coll Cardiol; 2021 Aug; 78(5):437-449. PubMed ID: 34325833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
    Grüneis R; Lamina C; Di Maio S; Schönherr S; Zoescher P; Forer L; Streiter G; Peters A; Gieger C; Köttgen A; Kronenberg F; Coassin S
    Atherosclerosis; 2022 May; 349():151-159. PubMed ID: 35534298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
    Coassin S; Erhart G; Weissensteiner H; Eca Guimarães de Araújo M; Lamina C; Schönherr S; Forer L; Haun M; Losso JL; Köttgen A; Schmidt K; Utermann G; Peters A; Gieger C; Strauch K; Finkenstedt A; Bale R; Zoller H; Paulweber B; Eckardt KU; Hüttenhofer A; Huber LA; Kronenberg F
    Eur Heart J; 2017 Jun; 38(23):1823-1831. PubMed ID: 28444229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
    Sun L; Zong M; Chen C; Xie L; Wu F; Yu M; Fan L
    Lipids Health Dis; 2018 May; 17(1):111. PubMed ID: 29747697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat.
    Grüneis R; Weissensteiner H; Lamina C; Schönherr S; Forer L; Di Maio S; Streiter G; Peters A; Gieger C; Kronenberg F; Coassin S
    J Lipid Res; 2022 Dec; 63(12):100306. PubMed ID: 36309064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.
    Lanktree MB; Anand SS; Yusuf S; Hegele RA;
    Circ Cardiovasc Genet; 2010 Feb; 3(1):39-46. PubMed ID: 20160194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive map of single-base polymorphisms in the hypervariable
    Coassin S; Schönherr S; Weissensteiner H; Erhart G; Forer L; Losso JL; Lamina C; Haun M; Utermann G; Paulweber B; Specht G; Kronenberg F
    J Lipid Res; 2019 Jan; 60(1):186-199. PubMed ID: 30413653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
    Coassin S; Kronenberg F
    Atherosclerosis; 2022 May; 349():17-35. PubMed ID: 35606073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
    Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
    J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
    Anderson JL; Knight S; May HT; Horne BD; Bair TL; Huntinghouse JA; Rollo JS; Muhlestein JB; Carlquist JF
    Am J Cardiol; 2013 Sep; 112(6):799-804. PubMed ID: 23735648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
    Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
    N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL; Zhai 翟天羽 TY; Ling 凌雁 Y; Gao 高鑫 X
    J Lipid Res; 2018 May; 59(5):884-891. PubMed ID: 29511049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats.
    Tolbus A; Mortensen MB; Nielsen SF; Kamstrup PR; Bojesen SE; Nordestgaard BG
    Clin Chem; 2017 Dec; 63(12):1866-1876. PubMed ID: 28971985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals.
    Di Maio S; Grüneis R; Streiter G; Lamina C; Maglione M; Schoenherr S; Öfner D; Thorand B; Peters A; Eckardt KU; Köttgen A; Kronenberg F; Coassin S
    Genome Med; 2020 Aug; 12(1):74. PubMed ID: 32825847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations.
    Noureen A; Fresser F; Utermann G; Schmidt K
    PLoS One; 2015; 10(3):e0121582. PubMed ID: 25822457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPA and PLG sequence variation and kringle IV-2 copy number in two populations.
    Crawford DC; Peng Z; Cheng JF; Boffelli D; Ahearn M; Nguyen D; Shaffer T; Yi Q; Livingston RJ; Rieder MJ; Nickerson DA
    Hum Hered; 2008; 66(4):199-209. PubMed ID: 18612205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a).
    Stefanutti C; Pisciotta L; Favari E; Di Giacomo S; Vacondio F; Zenti MG; Morozzi C; Berretti D; Mesce D; Vitale M; Pasta A; Ronca A; Garuti A; Manfredini M; Anglés-Cano E; Marcovina SM; Watts GF;
    J Clin Lipidol; 2020; 14(4):487-497.e1. PubMed ID: 32718857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
    Wang L; Chen J; Zeng Y; Wei J; Jing J; Li G; Su L; Tang X; Wu T; Zhou L
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1989-96. PubMed ID: 27417586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.